USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K

ISSN
15747891
Date Issued
2022
Author(s)
DOI
10.1002/1878-0261.13217
Subjects

Cancer Research

Genetics

Molecular Medicine

Oncology